Please login to the form below
EMLA
This page shows the latest EMLA news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca sells rights to seven anaesthetics in $770m deal
topical anaesthetics Diprivan (propofol) and EMLA (lidocain and prilocaine), plus five local anaesthetics.
Latest news
-
AstraZeneca UK launches Prostate Assistant mobile app
These including the EMLA Parent Planner app, for parents manage their child's day (and immunisation schedule), and two apps for doctors – AZ Quest cardiology app and the Lung Cancer – EGFR
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Wordbird
EMLA gynaecology. Secondary care advertisement. IPA Gold 2017 &2018. Awarded CPD Gold accreditation.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- Surviving cancer: a new era for patients
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
